Внесок користувача
- 20:00, 6 березня 2017 (різн. • історія) . . (+3878) . . Н However, it is probable that in this small subset of IGF2-low ACC other growth factors and signaling pathways compensate for low IGF2 expression, which creates opportunities for the design of other therapies targeting these factors (Створена сторінка: In addition, IGF2 expression did not affect substantially Akt and Erk phosphorylation, and therefore the action of the tyrosine kinase signaling pathways, even...)
- 16:04, 6 березня 2017 (різн. • історія) . . (+3671) . . Н In the present cohort, we found that the expression of IGF2 was 20-fold higher in ACC than in ACA, which confirms that IGF2 is the most differentially expressed gene between malignant and benign tumors (Створена сторінка: This growth-advertising result has also been shown in other adrenocortical tumor mobile lines: SW-13 cells do not convey substantial levels of IGF2 and mouse Y1...) (поточна)
- 17:01, 1 березня 2017 (різн. • історія) . . (0) . . м The lumen side of the SI was secured under a cover glass with a thin film of Vetbond (поточна)